Lilly, AstraZeneca, Cephalon Marketing Practices Under Review By House Committee
This article was originally published in The Pink Sheet Daily
Executive Summary
Rep. Waxman is requesting information into the marketing of Zyprexa, Seroquel, Actiq and Fentora.
You may also be interested in...
Cephalon Settles Federal Investigation Of Marketing Practices For $425 Million
Cephalon enters into a corporate integrity agreement with HHS Inspector General, which likely will be in line with its existing compliance program, firm tells “The Pink Sheet” DAILY.
Cephalon Settles Federal Investigation Of Marketing Practices For $425 Million
Cephalon enters into a corporate integrity agreement with HHS Inspector General, which likely will be in line with its existing compliance program, firm tells “The Pink Sheet” DAILY.
Cephalon Revises Fentora Labeling To Highlight Patient Selection Criteria Following Deaths
Among the deaths associated with the breakthrough cancer pain treatment were two patients prescribed the drug for migraines, Cephalon tells “The Pink Sheet” DAILY.